Enrique Freer
Papers
2
Total Citations
92
H-Index
2
About
Enrique Freer is a distinguished researcher whose work has significantly advanced the understanding and detection of human papillomavirus (HPV), a primary cause of cervical cancer. His key research areas include HPV genotyping methodologies, molecular epidemiology, and the long-term stability of cytologic specimens for cancer screening. Freer’s most impactful contribution is his highly cited 2008 study comparing two PCR-based HPV genotyping methods, which provided critical insights into the accuracy and reliability of detecting individual and carcinogenic HPV genotypes. This work, drawing on specimens from the landmark NCI/Costa Rica HPV16/18 vaccine trial, has garnered 83 citations and remains a foundational reference for optimizing HPV diagnostics. Additionally, his 2003 investigation into the stability of archived liquid-based cytologic specimens, though less cited, highlighted essential considerations for DNA preservation in cervical cancer screening, influencing biobanking practices. Freer’s research has directly informed global efforts to improve HPV detection, reduce cervical cancer incidence, and enhance the validity of large-scale epidemiological studies. His meticulous approach to method validation and specimen integrity underscores his lasting impact on molecular pathology and public health.
Research Focus
Key Achievements
Top Papers
- 1Comparison of Two PCR-Based Human Papillomavirus Genotyping Methods83 citations · 2008
- 2Stability of archived liquid-based cytologic specimens9 citations · 2003